02461nas a2200565 4500000000100000008004100001653001000042653001100052653001100063653000900074653000900083653001600092653001700108653001400125653001500139653003000154653002000184653002400204653001700228653002800245653001600273653001000289653002800299653003000327653001500357653002400372653003100396653003800427653003000465653001100495653003300506100001100539700001200550700001600562700001600578700001600594700001600610700001300626700002000639700002600659700001900685700001800704700002200722700002300744245006100767300001200828490000700840520103400847022001401881 2017 d10aAdult10aFemale10aHumans10aAged10aMale10aMiddle Aged10aRisk Factors10aPrognosis10aAdolescent10aSeverity of Illness Index10aResearch Design10aProspective Studies10aTime Factors10aCardiovascular Diseases10aYoung Adult10aIndia10aKidney Failure, Chronic10aRenal Replacement Therapy10abiomarkers10aDisease Progression10aGlomerular Filtration Rate10aGenetic Predisposition to Disease10aBiological Specimen Banks10aKidney10aRenal Insufficiency, Chronic1 aJha V.1 aJohn O.1 aKumar Vivek1 aYadav Ashok1 aGang Sishir1 aModi Gopesh1 aOjha Jai1 aPandey Rajendra1 aParameswaran Sreejith1 aPrasad Narayan1 aSahay Manisha1 aVarughese Santosh1 aBaid-Agarwal Seema00aIndian chronic kidney disease study: Design and methods. a273-2780 v223 a
AIM: The rate and factors that influence progression of chronic kidney disease (CKD) in developing countries like India are unknown. A pan-country prospective, observational cohort study is needed to address these knowledge gaps.
METHODS: The Indian Chronic Kidney Disease (ICKD) study will be a cohort study of approximately 5000 patients with mild to moderate CKD presenting to centres that represent different geographical regions in India. Time to 50% decline in baseline estimated glomerular filtration rate, need of renal replacement therapy or any new cardiovascular disease (CVD) event or death from CVD are the primary end points.
VALUE OF STUDY: This study will provide the opportunity to determine risk factors for CKD progression and development of CVD in Indian subjects and perform international comparisons to determine ethnic and geographical differences. A bio-repository will provide a chance to discover biomarkers and explore genetic risk factors.
a1440-1797